foxo4-dri senolytic peptide 2024 human trial Class II senolytics inhibit survival pathways elicited by senescent Stem Cell Peptide BPC-157 Net Wt:80g Freshwater
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15